This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: benefit

Pulmonary hypertension in UK clinical practice: an update

May 2015 Br J Cardiol 2015;22(suppl 1):S2–S15 doi:10.5837/bjc.2015.s01

Pulmonary hypertension in UK clinical practice: an update

Dr J Simon R Gibbs, Dr J Gerry Coghlan, Dr David G Kiely, Dr S John Wort

Abstract

(more…)

| Full text

May 2010 Br J Cardiol 2010;17:s14-s15

Costs and benefits of ARBs in practice

David Taylor, Mark Davis

Abstract

This brief paper considers how such cost pressures may affect the use of angiotensin receptor blockers (ARBs) in the NHS, given that although losartan is the first drug in this class to become generic in March 2010, others will quickly follow suit. Valsartan loses patent protection in 2011, with candesartan and irbesartan following in 2012. Indications for ARB use Recent data indicate that candesartan is presently the most widely used ARB in England, accounting for almost a third of all ARB prescriptions. This is in part because it has been competitively priced compared with other ARBs. In average prescription cost terms, candesartan has in r

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now